We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.51 | -1.68% | 29.82 | 29.82 | 30.03 | 30.15 | 29.81 | 29.92 | 3,381,439 | 21:00:05 |
From Apr 2019 to Apr 2024
By Cecilia Butini
Roche Holding AG said Tuesday that it plans to launch a high-volume antigen test to diagnose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections.
The test, which has been named Elecsys, is an automated laboratory assay for the detection of a coronavirus antigen, the company said.
It is performed by healthcare professionals via a nasopharyngeal or oropharyngeal swab in patients who show symptoms compatible with a coronavirus infection.
Roche added that the fully automated system on which Elecsys runs can provide test results in 18 minutes for a single test, excluding time for sample collection, transport and preparation.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
October 13, 2020 01:35 ET (05:35 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
